Concepedia

Mohammad Hasan Gholampoor Saadi

MH

Statistics

Publications

3

Citations

300

H-Index

3

Active since

2020

Affiliations

Shiraz University of Medical Sciences(Current)

Mohammad Hasan Gholampoor Saadi is an author at Shiraz University of Medical Sciences specializing in clinical trials, covid-19, and medicine.

ORCID

Top concepts

Publications per year

2020–2021

3

Publications

3

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh et al. · BMC Infectious Diseases · 2021 · 251 citations · Full text

COVID‐19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR

Zohre Khodamoradi, Seyed Ali Hosseini, Mohammad Hasan Gholampoor Saadi et al. · European Journal of Neurology · 2020 · 39 citations

Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh et al. · BMC Infectious Diseases · 2021 · 10 citations · Full text

, , +4

1–3 of 3